SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-020722
Filing Date
2016-06-21
Accepted
2016-06-21 16:04:42
Documents
1
Period of Report
2016-06-16
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K aimt-8k_20160616.htm 8-K 23116
  Complete submission text file 0001564590-16-020722.txt   24252
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37519 | Film No.: 161724429
SIC: 2834 Pharmaceutical Preparations